Skip to main content
Top
Published in: Surgery Today 3/2021

01-03-2021 | Billroth I Resection | Original Article

Pancreatic atrophy after gastrectomy for gastric cancer

Authors: Ryo Takahashi, Souya Nunobe, Naohito Sai, Rie Makuuchi, Satoshi Ida, Koshi Kumagai, Manabu Ohashi, Takeshi Sano

Published in: Surgery Today | Issue 3/2021

Login to get access

Abstract

Purpose

To investigate the phenomenon of pancreatic atrophy after gastrectomy for gastric cancer, using computed tomography (CT) volumetry.

Methods

The subjects of this retrospective study were 77 patients who underwent distal gastrectomy (DG) or total gastrectomy (TG) for pStage I gastric cancer in 2014. The relative pancreatic volume ratio was assessed preoperatively, and then 1 and 5 years postoperatively and the results were compared between surgical procedures

Results

A total of 14 patients underwent TG with Roux-en-Y (RY) reconstruction, 24 underwent DG with Billroth-I (BI) reconstruction, and 39 underwent DG with RY reconstruction. We observed that the pancreatic volume continued to decrease over the 5 years after DG or TG. Furthermore, the incidence of pancreatic atrophy 5 years postoperatively was significantly greater after TG than after DG. In patients who underwent DG, a greater incidence of pancreatic atrophy was observed after RY reconstruction than after BI reconstruction, 5 years postoperatively.

Conclusion

The pancreatic volume continued to decrease after DG and TG for gastric cancer 5 years after treatment. TG was associated with a significantly greater incidence of pancreatic atrophy than DG 5 years postoperatively, as was RY reconstruction vs. BI reconstruction after DG.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.CrossRef Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.CrossRef
3.
go back to reference Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients–is reconstruction with a reservoir worthwhile? Nutrition. 1999;15:677–82.CrossRef Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients–is reconstruction with a reservoir worthwhile? Nutrition. 1999;15:677–82.CrossRef
5.
go back to reference Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55–73.PubMedPubMedCentral Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55–73.PubMedPubMedCentral
6.
go back to reference Antonini F, Crippa S, Falconi M, Macarri G, Pezzilli R. Pancreatic enzyme replacement therapy after gastric resection: an update. Dig Liver Dis. 2018;50:1–5.CrossRef Antonini F, Crippa S, Falconi M, Macarri G, Pezzilli R. Pancreatic enzyme replacement therapy after gastric resection: an update. Dig Liver Dis. 2018;50:1–5.CrossRef
7.
go back to reference Straatman J, Wiegel J, van der Wielen N, Jansma EP, Cuesta MA, van der Peet DL. Systematic review of exocrine pancreatic insufficiency after gastrectomy for cancer. Dig Surg. 2017;34:364–70.CrossRef Straatman J, Wiegel J, van der Wielen N, Jansma EP, Cuesta MA, van der Peet DL. Systematic review of exocrine pancreatic insufficiency after gastrectomy for cancer. Dig Surg. 2017;34:364–70.CrossRef
8.
go back to reference Geraghty EM, Boone JM, McGahan JP, Jain K. Normal organ volume assessment from abdominal CT. Abdom Imaging. 2004;29:482–90.CrossRef Geraghty EM, Boone JM, McGahan JP, Jain K. Normal organ volume assessment from abdominal CT. Abdom Imaging. 2004;29:482–90.CrossRef
9.
go back to reference Szczepaniak EW, Malliaras K, Nelson MD, Szczepaniak LS. Measurement of pancreatic volume by abdominal MRI: a validation study. PLoS ONE. 2013;8:e55991.CrossRef Szczepaniak EW, Malliaras K, Nelson MD, Szczepaniak LS. Measurement of pancreatic volume by abdominal MRI: a validation study. PLoS ONE. 2013;8:e55991.CrossRef
10.
go back to reference Williams AJ, Chau W, Callaway MP, Dayan CM. Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes. Diabet Med. 2007;24:35–40.CrossRef Williams AJ, Chau W, Callaway MP, Dayan CM. Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes. Diabet Med. 2007;24:35–40.CrossRef
11.
go back to reference Schrader H, Menge BA, Schneider S, Belyaev O, Tannapfel A, Uhl W, et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology. 2009;136:513–22.CrossRef Schrader H, Menge BA, Schneider S, Belyaev O, Tannapfel A, Uhl W, et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology. 2009;136:513–22.CrossRef
12.
go back to reference Campbell-Thompson M, Rodriguez-Calvo T, Battaglia M. Abnormalities of the exocrine pancreas in Type 1 diabetes. Curr Diabetes Rep. 2015;15:79.CrossRef Campbell-Thompson M, Rodriguez-Calvo T, Battaglia M. Abnormalities of the exocrine pancreas in Type 1 diabetes. Curr Diabetes Rep. 2015;15:79.CrossRef
13.
go back to reference Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3:17060.CrossRef Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3:17060.CrossRef
14.
go back to reference Lu J, Guo M, Wang H, Pan H, Wang L, Yu X, et al. Association between pancreatic atrophy and loss of insulin secretory capacity in patients with Type 2 diabetes mellitus. J Diabetes Res. 2019;2019:6371231.PubMedPubMedCentral Lu J, Guo M, Wang H, Pan H, Wang L, Yu X, et al. Association between pancreatic atrophy and loss of insulin secretory capacity in patients with Type 2 diabetes mellitus. J Diabetes Res. 2019;2019:6371231.PubMedPubMedCentral
15.
go back to reference Hashimoto N, Yasuda T, Haji S, Nomura H, Ohyanagi H. Comparison of the functional and morphological changes in the pancreatic remnant between pylorus-preserving pancreatoduodenectomy and pancreatoduodenectomy. Hepatogastroenterology. 2003;50:2229–32.PubMed Hashimoto N, Yasuda T, Haji S, Nomura H, Ohyanagi H. Comparison of the functional and morphological changes in the pancreatic remnant between pylorus-preserving pancreatoduodenectomy and pancreatoduodenectomy. Hepatogastroenterology. 2003;50:2229–32.PubMed
16.
go back to reference Kim JH, Yoo BM, Kim JH, Kim WH. Which method should we select for pancreatic anastomosis after pancreaticoduodenectomy? World J Surg. 2009;33:326–32.CrossRef Kim JH, Yoo BM, Kim JH, Kim WH. Which method should we select for pancreatic anastomosis after pancreaticoduodenectomy? World J Surg. 2009;33:326–32.CrossRef
17.
go back to reference Tomimaru Y, Takeda Y, Kobayashi S, Marubashi S, Lee CM, Tanemura M, et al. Comparison of postoperative morphological changes in remnant pancreas between pancreaticojejunostomy and pancreaticogastrostomy after pancreaticoduodenectomy. Pancreas. 2009;38:203–7.CrossRef Tomimaru Y, Takeda Y, Kobayashi S, Marubashi S, Lee CM, Tanemura M, et al. Comparison of postoperative morphological changes in remnant pancreas between pancreaticojejunostomy and pancreaticogastrostomy after pancreaticoduodenectomy. Pancreas. 2009;38:203–7.CrossRef
18.
go back to reference Klupp F, Klauss M, Rahbari NN, Felix K, Hinz U, Manglberger I, et al. Volume changes of the pancreatic head remnant after distal pancreatectomy. Surgery. 2020;167:455–67.CrossRef Klupp F, Klauss M, Rahbari NN, Felix K, Hinz U, Manglberger I, et al. Volume changes of the pancreatic head remnant after distal pancreatectomy. Surgery. 2020;167:455–67.CrossRef
19.
go back to reference Takahashi K, Sasaki R, Kondo T, Oda T, Murata S, Ohkohchi N. Preoperative 3D volumetric analysis for liver congestion applied in a patient with hilar cholangiocarcinoma. Langenbecks Arch Surg. 2010;395:761–5.CrossRef Takahashi K, Sasaki R, Kondo T, Oda T, Murata S, Ohkohchi N. Preoperative 3D volumetric analysis for liver congestion applied in a patient with hilar cholangiocarcinoma. Langenbecks Arch Surg. 2010;395:761–5.CrossRef
20.
go back to reference Mise Y, Tani K, Aoki T, Sakamoto Y, Hasegawa K, Sugawara Y, et al. Virtual liver resection: computer-assisted operation planning using a three-dimensional liver representation. J Hepatobiliary Pancreat Sci. 2013;20:157–64.CrossRef Mise Y, Tani K, Aoki T, Sakamoto Y, Hasegawa K, Sugawara Y, et al. Virtual liver resection: computer-assisted operation planning using a three-dimensional liver representation. J Hepatobiliary Pancreat Sci. 2013;20:157–64.CrossRef
21.
go back to reference Nakayama K, Oshiro Y, Miyamoto R, Kohno K, Fukunaga K, Ohkohchi N. The effect of three-dimensional preoperative simulation on liver surgery. World J Surg. 2017;41:1840–7.CrossRef Nakayama K, Oshiro Y, Miyamoto R, Kohno K, Fukunaga K, Ohkohchi N. The effect of three-dimensional preoperative simulation on liver surgery. World J Surg. 2017;41:1840–7.CrossRef
22.
go back to reference Miyamoto R, Oshiro Y, Sano N, Inagawa S, Ohkohchi N. Three-Dimensional remnant pancreatic volumetry predicts postoperative pancreatic fistula in pancreatic cancer patients after pancreaticoduodenectomy. Gastrointest Tumors. 2019;5:90–9.CrossRef Miyamoto R, Oshiro Y, Sano N, Inagawa S, Ohkohchi N. Three-Dimensional remnant pancreatic volumetry predicts postoperative pancreatic fistula in pancreatic cancer patients after pancreaticoduodenectomy. Gastrointest Tumors. 2019;5:90–9.CrossRef
23.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
24.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transpl. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transpl. 2013;48:452–8.CrossRef
25.
go back to reference Dominguez-Munoz JE. Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery. HPB (Oxford). 2009;11(Suppl 3):3–6.CrossRef Dominguez-Munoz JE. Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery. HPB (Oxford). 2009;11(Suppl 3):3–6.CrossRef
26.
go back to reference Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933–42.CrossRef Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933–42.CrossRef
27.
go back to reference Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRef Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRef
28.
go back to reference Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–8.CrossRef Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–8.CrossRef
29.
go back to reference Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001;50:227–32.CrossRef Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001;50:227–32.CrossRef
30.
go back to reference Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138:1312–20.CrossRef Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138:1312–20.CrossRef
31.
go back to reference Pandol SJ. Colloquium series on integrated systems physiology: from molecule to function to disease. Exocrine Pancreas. 2010;3:1–64. Pandol SJ. Colloquium series on integrated systems physiology: from molecule to function to disease. Exocrine Pancreas. 2010;3:1–64.
32.
go back to reference Whitcomb DC, Frulloni L, Garg P, Greer JB, Schneider A, Yadav D, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16:218–24.CrossRef Whitcomb DC, Frulloni L, Garg P, Greer JB, Schneider A, Yadav D, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16:218–24.CrossRef
33.
go back to reference Armbrecht U, Lundell L, Stockbruegger RW. Nutrient malassimilation after total gastrectomy and possible intervention. Digestion. 1987;37(Suppl 1):56–60.CrossRef Armbrecht U, Lundell L, Stockbruegger RW. Nutrient malassimilation after total gastrectomy and possible intervention. Digestion. 1987;37(Suppl 1):56–60.CrossRef
34.
go back to reference Armbrecht U, Lundell L, Stockbrugger RW. The benefit of pancreatic enzyme substitution after total gastrectomy. Aliment Pharmacol Ther. 1988;2:493–500.CrossRef Armbrecht U, Lundell L, Stockbrugger RW. The benefit of pancreatic enzyme substitution after total gastrectomy. Aliment Pharmacol Ther. 1988;2:493–500.CrossRef
35.
go back to reference Bragelmann R, Armbrecht U, Rosemeyer D, Schneider B, Zilly W, Stockbrugger RW. The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur J Gastroenterol Hepatol. 1999;11:231–7.CrossRef Bragelmann R, Armbrecht U, Rosemeyer D, Schneider B, Zilly W, Stockbrugger RW. The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy. Eur J Gastroenterol Hepatol. 1999;11:231–7.CrossRef
36.
go back to reference Catarci M, Berlanda M, Grassi GB, Masedu F, Guadagni S. Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial. Gastric Cancer. 2018;21:542–51.CrossRef Catarci M, Berlanda M, Grassi GB, Masedu F, Guadagni S. Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial. Gastric Cancer. 2018;21:542–51.CrossRef
37.
go back to reference Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, et al. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol. 2013;19:7930–46.CrossRef Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, et al. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol. 2013;19:7930–46.CrossRef
38.
go back to reference Vujasinovic M, Valente R, Thorell A, Rutkowski W, Haas SL, Arnelo U, et al. Pancreatic exocrine insufficiency after bariatric surgery. Nutrients. 2017;9:1241.CrossRef Vujasinovic M, Valente R, Thorell A, Rutkowski W, Haas SL, Arnelo U, et al. Pancreatic exocrine insufficiency after bariatric surgery. Nutrients. 2017;9:1241.CrossRef
Metadata
Title
Pancreatic atrophy after gastrectomy for gastric cancer
Authors
Ryo Takahashi
Souya Nunobe
Naohito Sai
Rie Makuuchi
Satoshi Ida
Koshi Kumagai
Manabu Ohashi
Takeshi Sano
Publication date
01-03-2021
Publisher
Springer Singapore
Published in
Surgery Today / Issue 3/2021
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-020-02131-2

Other articles of this Issue 3/2021

Surgery Today 3/2021 Go to the issue